Long-term Follow-up of Kidney Transplant Recipients in the Spare-the-Nephron-Trial
Matthew R. Weir(University of Maryland, Baltimore), Robert D. Gordon, Thomas C. Pearson(Emory Healthcare), Lawrence Chan(Baylor College of Medicine), John D. Scandling(Stanford Medicine), David McCollum(University of Maryland, Baltimore), Prabhakar K. Baliga(Medical University of South Carolina), Heidi Schaefer(University of Maryland, Baltimore), Roberto Kalil(University of Maryland, Baltimore), Lali Anandagoda(University of Maryland, Baltimore), V. Ram Peddi(University of Maryland, Baltimore), Thomas Waid(University of Kentucky), Shamkant Mulgaonkar(Saint Barnabas Medical Center), Larry B. Melton(University of Maryland, Baltimore), Anita Patel(University of Maryland, Baltimore), Sibylle Lawson(University of Maryland, Baltimore), Nasser Youssef(University of Maryland, Baltimore)
Cited by 20
Related Papers
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways
|Nature|1996|1.5k
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
|The Journal of Experimental Medicine|1997|802
Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties
|American Journal of Transplantation|2005|714
Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors
|New England Journal of Medicine|2014|658
MYH9 is associated with nondiabetic end-stage renal disease in African Americans
|Nature Genetics|2008|648